KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Income towards Parent Company: 2016-2024

Historic Income towards Parent Company for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to $338.0 million.

  • Elanco Animal Health's Income towards Parent Company fell 109.34% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 82.44%. This contributed to the annual value of $338.0 million for FY2024, which is 127.46% up from last year.
  • Elanco Animal Health's Income towards Parent Company amounted to $338.0 million in FY2024, which was up 127.46% from -$1.2 billion recorded in FY2023.
  • Elanco Animal Health's 5-year Income towards Parent Company high stood at $338.0 million for FY2024, and its period low was -$1.2 billion during FY2023.
  • For the 3-year period, Elanco Animal Health's Income towards Parent Company averaged around -$323.7 million, with its median value being -$78.0 million (2022).
  • As far as peak fluctuations go, Elanco Animal Health's Income towards Parent Company plummeted by 1,478.21% in 2023, and later surged by 127.46% in 2024.
  • Elanco Animal Health's Income towards Parent Company (Yearly) stood at -$574.0 million in 2020, then grew by 15.85% to -$483.0 million in 2021, then soared by 83.85% to -$78.0 million in 2022, then slumped by 1,478.21% to -$1.2 billion in 2023, then soared by 127.46% to $338.0 million in 2024.